{"id":"https://openalex.org/W14860905","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","title":"Reversal of adverse effects of neoadjuvant chemotherapy on bone turnover in pre- and post-menopausal women with zoledronic acid","display_name":"Reversal of adverse effects of neoadjuvant chemotherapy on bone turnover in pre- and post-menopausal women with zoledronic acid","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W14860905","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","mag":"14860905"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.556","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054757298","display_name":"Rebecca Aft","orcid":"https://orcid.org/0000-0001-8569-7131","observed_orcids":["https://orcid.org/0000-0001-8569-7131"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Aft","raw_affiliation_strings":["Washington University, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022533358","display_name":"Lars Robert McNaughton","orcid":"https://orcid.org/0000-0002-3743-3171","observed_orcids":["https://orcid.org/0000-0002-3743-3171"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Naughton","raw_affiliation_strings":["Washington University, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028178596","display_name":"K. Trinkuas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Trinkuas","raw_affiliation_strings":["Washington University, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007830810","display_name":"Mark A. Watson","orcid":"https://orcid.org/0000-0002-3935-9980","observed_orcids":["https://orcid.org/0000-0002-3935-9980"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Watson","raw_affiliation_strings":["Washington University, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013118794","display_name":"KN Weilbaecher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Weilbaecher","raw_affiliation_strings":["Washington University, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204465549"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"556","last_page":"556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":0.9620000123977661},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8600000143051147},{"id":"https://openalex.org/keywords/bone-turnover-markers","display_name":"bone turnover markers","score":0.9769999980926514},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.871999979019165},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.7820000052452087},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pegylated-g-csf","display_name":"pegylated G-CSF","score":0.9269999861717224},{"id":"https://openalex.org/keywords/bone-resorption","display_name":"bone resorption","score":0.6819999814033508},{"id":"https://openalex.org/keywords/urinary-n-telopeptide","display_name":"urinary N-telopeptide","score":0.8040000200271606},{"id":"https://openalex.org/keywords/bone-specific-alkaline-phosphatase","display_name":"bone-specific alkaline phosphatase","score":0.9340000152587891},{"id":"https://openalex.org/keywords/osteocalcin","display_name":"osteocalcin","score":0.996999979019165},{"id":"https://openalex.org/keywords/menopause","display_name":"menopause","score":0.6290000081062317},{"id":"https://openalex.org/keywords/chemotherapy-induced-bone-loss","display_name":"chemotherapy-induced bone loss","score":0.625}],"concepts":[{"id":"https://openalex.org/C2776326535","wikidata":"https://www.wikidata.org/wiki/Q218507","display_name":"Zoledronic acid","level":2,"score":0.8948261737823486},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8931629061698914},{"id":"https://openalex.org/C170033053","wikidata":"https://www.wikidata.org/wiki/Q952019","display_name":"Bone remodeling","level":2,"score":0.7156543731689453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.627582848072052},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6220531463623047},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5267440676689148},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.5256953239440918},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5097717642784119},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4966581463813782},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.49145734310150146},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.48645660281181335},{"id":"https://openalex.org/C125870589","wikidata":"https://www.wikidata.org/wiki/Q16959485","display_name":"N-terminal telopeptide","level":5,"score":0.44772958755493164},{"id":"https://openalex.org/C131075544","wikidata":"https://www.wikidata.org/wiki/Q415863","display_name":"Osteocalcin","level":4,"score":0.3818969428539276},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3623943328857422},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32665812969207764},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.2234111726284027},{"id":"https://openalex.org/C160160445","wikidata":"https://www.wikidata.org/wiki/Q24769688","display_name":"Alkaline phosphatase","level":3,"score":0.1961682140827179},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.556","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964337669","https://openalex.org/W749579776","https://openalex.org/W1983174515","https://openalex.org/W2018198978","https://openalex.org/W2327803383","https://openalex.org/W3021707980","https://openalex.org/W1998650954","https://openalex.org/W2248766932","https://openalex.org/W2114581944","https://openalex.org/W2146657065"],"abstract_inverted_index":{"556":[0],"Background:":[1],"Ovarian":[2],"failure":[3],"secondary":[4],"to":[5,10,20,76,111,268],"adjuvant":[6],"chemotherapy":[7,28,65,123,168,183,205,230,256],"is":[8,199],"known":[9],"have":[11,39],"an":[12],"adverse":[13],"effect":[14],"on":[15,48],"bone":[16,22,57,138,211,239,261],"mineral":[17],"density":[18],"and":[19,78,100,193,217,226,234,245],"increase":[21,259],"turnover":[23,58,131,212,262],"markers.":[24,263],"The":[25,43],"effects":[26],"of":[27,36,45,82,96,148,166,221,255],"with":[29,86,90,122,181,206,231,252],"growth":[30,207,235],"factor":[31,208,236],"support":[32,89,209,237],"in":[33,60,159,188,214,242,260],"the":[34,200],"absence":[35],"hormonal":[37],"changes":[38,50],"not":[40],"been":[41],"described.":[42],"impact":[44],"zoledronic":[46,93,113,178],"acid":[47,114,179,249],"these":[49],"was":[51],"also":[52],"explored.":[53],"Methods:":[54],"We":[55],"evaluated":[56],"markers":[59,132,213,241],"82":[61],"women":[62,219],"undergoing":[63],"neoadjuvant":[64,167,182],"for":[66,105],"localized":[67],"stage":[68],"II/III":[69],"breast":[70],"cancer":[71],"at":[72],"initial":[73],"diagnosis":[74],"prior":[75],"treatment":[77,128],"after":[79,163],"4":[80,115],"cycles":[81],"epirubicin":[83],"(75mg/m2)-docetaxel":[84],"(75mg/m2)":[85],"pegylated":[87],"G-CSF":[88],"or":[91],"without":[92],"acid.":[94],"47%":[95],"patients":[97],"were":[98,103,109],"post-menopausal":[99,216,244],"all":[101],"groups":[102],"balanced":[104],"other":[106],"variables.":[107],"Women":[108,175],"randomized":[110],"receive":[112],"mg":[116],"IV":[117],"every":[118],"3":[119,164],"weeks":[120],"concurrently":[121,180,251],"(n=41)":[124],"versus":[125],"no":[126,153],"bisphosphonate":[127,154],"(n=41).":[129],"Bone":[130],"included:":[133],"urinary":[134],"N-telopeptide":[135],"(NTx),":[136],"serum":[137],"specific":[139],"alkaline":[140],"phosphatase":[141],"(BAP)and":[142],"osteocalcin":[143],"(OSTEO).":[144],"Results:":[145],"Women,":[146],"regardless":[147],"menopausal":[149],"status,":[150],"who":[151,176],"received":[152,177],"had":[155,184],"statistically":[156,185],"significant":[157,186,265],"increases":[158],"NTx,":[160],"from":[161,196],"baseline":[162],"months":[165],"using":[169],"multivariable":[170],"mixed":[171],"repeated":[172],"measures":[173],"(p=0.0213).":[174],"decreases":[187],"NTx":[189],"(p<0.0001),":[190],"BAP":[191],"(p<0.0001)":[192],"OSTEO":[194],"(p=0.0295)":[195],"baseline.":[197],"This":[198],"first":[201],"demonstration":[202],"that":[203],"anthracycline-taxane":[204],"increased":[210,238],"both":[215,243],"pre-menopausal":[218,246],"independent":[220],"hormone":[222],"therapy,":[223],"radiation":[224],"therapy":[225],"surgery.":[227],"Conclusions:":[228],"Neoadjuvant":[229],"anthracycline-":[232],"taxane":[233],"resorption":[240],"women.":[247],"Zoledronic":[248],"given":[250],"each":[253],"cycle":[254],"reversed":[257],"this":[258],"No":[264],"financial":[266],"relationships":[267],"disclose.":[269]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}